Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion

被引:31
作者
Colombo, B
Longhi, R
Marinzi, C
Magni, F
Cattaneo, A
Yoo, SH
Curnis, F
Corti, A
机构
[1] San Raffaele H Sci Inst, Dept Biol & Technol Res, I-20132 Milan, Italy
[2] ICRM, CNR, I-20132 Milan, Italy
[3] Inha Univ, Coll Med, Dept Biochem,Nam Gu, Natl Creat Res Initiat Ctr Secretory Granule Res, Inchon 402751, South Korea
关键词
D O I
10.1074/jbc.M202637200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been proposed that chromogranin A (CgA), a protein secreted by many normal and neoplastic neuroendocrine cells, can play a role as a positive or a negative modulator of cell adhesion. The mechanisms that regulate these extracellular functions of CgA are unknown. We show here that plasmin can regulate the anti/pro-adhesive activity of CgA by proteolytic cleavage of the N-terminal domain. Limited proteolytic processing decreased its anti-adhesive activity and induced pro-adhesive effects in fibronectin or serum-dependent fibroblast adhesion assays. Cleavage of LyS77 -LyS78 dibasic site in CgA(1-115) was relatively rapid and associated with an increase of pro-adhesive effect. In contrast, antibodies against the region 53-90 enhanced the anti-adhesive activity of CgA and CgA(1-115). Structure-activity relationship studies showed that the conserved region 47-64 (RILSILRHQNLLKELQDL) is critical for both pro- and anti-adhesive activity. These findings suggest that CgA might work on one hand as a negative modulator of cell adhesion and on the other hand as a precursor of positive modulators, the latter requiring proteolytic processing for activation. Given the importance of plasminogen activation in tissue invasion and remodeling, the interplay between CgA and plasmin could provide a novel mechanism for regulating fibroblast adhesion and function in neuroendocrine tumors.
引用
收藏
页码:45911 / 45919
页数:9
相关论文
共 53 条
[1]   VASOSTATINS, COMPRISING THE N-TERMINAL DOMAIN OF CHROMOGRANIN-A, SUPPRESS TENSION IN ISOLATED HUMAN BLOOD-VESSEL SEGMENTS [J].
AARDAL, S ;
HELLE, KB ;
ELSAYED, S ;
REED, RK ;
SERCKHANSSEN, G .
JOURNAL OF NEUROENDOCRINOLOGY, 1993, 5 (04) :405-412
[2]   THE VASOINHIBITORY ACTIVITY OF BOVINE CHROMOGRANIN-A FRAGMENT (VASOSTATIN) AND ITS INDEPENDENCE OF EXTRACELLULAR CALCIUM IN ISOLATED SEGMENTS OF HUMAN BLOOD-VESSELS [J].
AARDAL, S ;
HELLE, KB .
REGULATORY PEPTIDES, 1992, 41 (01) :9-18
[3]  
BRANDT DW, 1994, P SOC EXP BIOL MED, V205, P316
[4]   Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality [J].
Ceconi, C ;
Ferrari, R ;
Bachetti, T ;
Opasich, C ;
Volterrani, M ;
Colombo, B ;
Parrinello, G ;
Corti, A .
EUROPEAN HEART JOURNAL, 2002, 23 (12) :967-974
[5]   Chromogranin A induces a neurotoxic phenotype in brain microglial cells [J].
Ciesielski-Treska, J ;
Ulrich, G ;
Taupenot, L ;
Chasserot-Golaz, S ;
Corti, A ;
Aunis, D ;
Bader, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14339-14346
[6]  
Colombo B, 2002, CANCER RES, V62, P941
[7]   THE UROKINASE UROKINASE-RECEPTOR SYSTEM AND CANCER - INVASION [J].
CONESE, M ;
BLASI, F .
BAILLIERES CLINICAL HAEMATOLOGY, 1995, 8 (02) :365-389
[8]   Production and structure characterisation of recombinant chromogranin A N-terminal fragments (vasostatins) - Evidence of dimer-monomer equilibria [J].
Corti, A ;
Sanchez, LP ;
Gasparri, A ;
Curnis, F ;
Longhi, R ;
Brandazza, A ;
Siccardi, AG ;
Sidoli, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 248 (03) :692-699
[9]   Antigenic regions of human chromogranin A and their topographic relationships with structural functional domains [J].
Corti, A ;
Longhi, R ;
Gasparri, A ;
Chen, FX ;
Pelagi, M ;
Siccardi, AG .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2) :275-280
[10]  
Corti A, 2000, ADV EXP MED BIOL, V482, P351